Cargando…
Safety and Feasibility of a Novel Percutaneous Locoregional Injection Technique of Renal Cellular Therapy for Chronic Kidney Disease of Diabetes
Autores principales: | Yu, Hyeon, Sonntag, Paul D., Bream, Peter R., Lazarowicz, Michael P., Nowakowski, Francis S., Woodhead, Gregory J., Hennemeyer, Charles T., Muller, Ryan D., Navuluri, Rakesh, Caoili, Elaine M., Eifler, Aaron C., Tominna, Brandon S., Stavas, Joseph M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418969/ https://www.ncbi.nlm.nih.gov/pubmed/34514211 http://dx.doi.org/10.1016/j.ekir.2021.06.014 |
Ejemplares similares
-
Congenital tracheobiliary fistula combined with hypoplastic common hepatic duct: Management by percutaneous transhepatic drainage
por: Yu, Hyeon, et al.
Publicado: (2015) -
Friend or Foe? Locoregional Therapies and Immunotherapies in the Current Hepatocellular Treatment Landscape
por: Young, Shamar, et al.
Publicado: (2023) -
Percutaneous treatment of IVC obstruction due to post-resection hepatic torsion associated with IVC thrombosis
por: Van Ha, Thuong G., et al.
Publicado: (2019) -
Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
por: Iezzi, Roberto, et al.
Publicado: (2023) -
Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies
por: Yutani, Shigeru, et al.
Publicado: (2017)